Tuesday 14 September - Conference Day Two
| |
Morning Session Chair: Dr Dave Ager, DSM Research, USA |
| 08.25 |
Opening Remarks
|
| 08.30 |
Dr Ian Lennon, Chiral Quest Ltd, UK
Asymmetric Hydrogenation Technology for Old and New Pharmaceutical Intermediates
|
| 09.15 |
Dr William Heggie, Hovione FarmaCiencia SA, Portugal
Tamsulosin: Process Development
|
| 10.00 |
Dr Steve Collier, Codexis, USA
The Development of Commercial Biocatalytic Processes to Simvastatin and Other Molecules Using Highly Evolved Enzymes
|
| 10.45 |
Coffee and Exhibition |
| 11.30 |
Mr Ian Moses, Pfizer Global R&D UK
Synthesis and Scale-Up of a Small-Molecule MC4 Receptor Agonist
|
| 12.15 |
Dr Philippe Vayron, Sanofi-Aventis, France
Amibegron: Process Development of a Chiral Amino-Alcohol
|
| 13.00 |
Lunch and Exhibition
|
14.00
|
OPTIONAL SHORT COURSE
Grignard Reactions in Proces Development
Tutor:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 , Scientific Update
This half-day course will include a short introduction, practical considerations on the formation of Grignard reagents, solvent effects, safety issues and recent developments in the field of Grignard chemistry.
|
| 17.30 |
End of Day Two |
